TABLE 1.
Study population demographics
| Characteristic | Value for vaccine group |
|||
|---|---|---|---|---|
| Flexyn2a (n = 12) | Flexyn2a + alum (n = 12) | Placebo (n = 6) | Total (n = 30) | |
| Age (yrs), mean (min–max) | 30 (19–50) | 31 (21–48) | 32 (21–50) | 31 (19–50) |
| Gender female, no. (%) | 3 (25) | 5 (42) | 3 (50) | 11 (37) |
| Ethnicity, no. (%) | ||||
| Hispanic or Latino | 3 (25) | 2 (17) | 5 (17) | |
| Non-Hispanic or non-Latino | 9 (75) | 10 (83) | 6 (100) | 25 (83) |
| Race, no. (%) | ||||
| Asian | 1 (8) | 1 (3) | ||
| Black | 4 (33) | 3 (25) | 3 (50) | 10 (33) |
| Multiracial | 2 (17) | 1 (8) | 3 (10) | |
| White | 5 (42) | 8 (67) | 3 (50) | 16 (54) |